Award
National Institute of Neurological Disorders and Stroke 1R01NS143106-01A1
Targeting Glioblastoma with Multifunctional Anti-RAGE Oligonucleotides
Recipient
Beckman Research Institute/City of Hope
Award Amount
$548,395.00
Ceiling
$548,395.00
Awarded
May 01, 2026
Identifier
1R01NS143106-01A1
Award for research project targeting glioblastoma using multifunctional anti-RAGE oligonucleotides to develop novel therapies, with a focus on drug optimization and immunotherapy combination.
Description
This project involves developing drugs that inhibit RAGE activity in glioblastoma tumors, aiming to create a novel therapy for glioblastoma and other cancers. The project includes optimizing anti-RAGE oligo strategies, testing in vivo efficacy, and combining with immunotherapy.